top of page

Harnessing the Full Potential of Protein Degradation through Identification of Novel Targets
Home: Welcome
Our Purpose
f5 Therapeutics is a privately held, pharmaceutical company that focuses on targeted protein degradation via ‘molecular glues.’ Our NExMod™ (Neosubstrate Expression Modulators) platform focuses on discovering novel targets for degradation to combat human disease across multiple therapeutic areas. Utilizing our proprietary methods, we have discovered multiple novel neosubstrates with the potential to revolutionize cancer care.
Home: Products
bottom of page